Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018.

BMC infectious diseases - 9 Jul 2021

Wang Zhen, Zhao Bin, An Minghui, Song Wei, Dong Xue, Li Xin, Wang Lu, Wang Lin, Tian Wen, Ding Haibo, Han Xiaoxu

Abstract excerpt

BACKGROUND: To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. METHODS: Demographic and epidemiological information of all newly diagnosed HIV-1 infected residents in Shenyang city from 2016 to 2018 were anonymously collected from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Emtricitabine

Share to Epidemics

Share to HIV Infections

Share to Reverse Transcriptase Inhibitors

Share to Tenofovir

Source

Open in PubMed Open full text

Identifiers

PMID: 34243716
DOI: 10.1186/s12879-021-06312-3
PMCID: PMC8268309

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018.PMID 34243716Read ↗

Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing.Semantic proximity Read ↗

Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023.Semantic proximity Read ↗

Prevalence of Transmitted HIV-1 Drug Resistance Among Treatment-naive Individuals in China, 2000-2016Semantic proximity Read ↗

Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in ChinaSemantic proximity Read ↗

Prevalence of transmitted HIV-1 drug resistance among treatment-naive individuals in China, 2000-2016.Semantic proximity Read ↗

Changing Proportions of HIV-1 Subtypes and Transmitted Drug Resistance Among Newly Diagnosed HIV/AIDS Individuals — China, 2015 and 2018Semantic proximity Read ↗

The HIV-1 Transmitted Drug Resistance in Newly Confirmed and ART-Naïve HIV-1-Infected MSM in Zhenjiang City, Jiangsu, China.Semantic proximity Read ↗

Molecular surveillance of HIV-1 newly diagnosed infections in Shenzhen, China from 2011 to 2018.Semantic proximity Read ↗

[Survey of HIV-1 drug resistance threshold in Shandong Province in 2013-2015].Semantic proximity Read ↗

Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013.Semantic proximity Read ↗

Transmitted HIV-1 Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey.Semantic proximity Read ↗

Transmitted Drug Resistance Among People Living With HIV-1 in Henan Province, China, 2025Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.